✦ LIBER ✦

242 HCC RECURRENCE AFTER LIVER TRANSPLANTATION: ROLE OF IMMUNOSUPPRESSION WITH CALCINEURIN INHIBITORS

✍ Scribed by M. Vivarelli; A. Cucchetti; G. La Barba; M. Cescon; M. Del Gaudio; G. Ercolani; A. Lauro; M. Ravaioli; G.L. Grazi; A.D. Pinna

Book ID: 117376168
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 67 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60244-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunosuppression with calcineurin inhib

Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: Results of a meta-analysis

✍ Marina Berenguer; Ana Royuela; Javier Zamora 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

265 HBV recurrence associated with HCC r

265 HBV recurrence associated with HCC recurrence after liver transplantation: Role of HBV production from tumoral cells

✍ B. Roche; M. Gigou; A.M. Roque-Afonso; M. Sebagh; C. Guettier; E. Dussaix; D. Sa 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Reduced exposure to calcineurin inhibito

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma

✍ Rodríguez-Perálvarez, Manuel; Tsochatzis, Emmanuel; Naveas, María Carmen; Pieri, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 691 KB

Role of immunosuppression in recurrence

Role of immunosuppression in recurrence after liver transplantation for diethylnitrosamine-induced tumors in rats

✍ A. Ceriello; F. Mezza; S. Cozzolino; G. Pettinato; A. Mancini; W. Santaniello; F 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 280 KB

Immunosuppression and donor age with res

Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation

✍ Dimitrios N. Samonakis; Christos K. Triantos; Ulrich Thalheimer; Alberto Quaglia 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

In HCV cirrhotic patients after liver transplantation, survival and recurrence of HCV appears to be worsening in recent years. Donor age has been suggested as a cause. However, it is not clear if early and/or late mortality is affected and whether donor age is a key factor, as opposed to changes in

Prospective Study of Everolimus With Cal

Prospective Study of Everolimus With Calcineurin Inhibitor-Free Immunosuppression After Heart Transplantation: Results at Four Years

✍ Engelen, Markus A.; Welp, Henryk A.; Gunia, Stefan; Amler, Susanne; Klarner, Mor 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 131 KB